Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | BMRN | HALO | ||
| Company | Arrowhead Pharma | Biomarin Pharmaceuticals | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 88.23 | 68.11 | 106.41 | ||
| High | 88.45 | 68.75 | 107.44 | ||
| Low | 85.90 | 67.57 | 105.20 | ||
| Last | 87.47 | 67.68 | 106.12 | ||
| Change | -1.94 | -1.65 | -1.50 | ||
| Percent Change | -2.17% | -2.38% | -1.39% | ||
| Volume | 896,837 | 1,275,578 | 1,577,456 | ||
| 20-Day Average Volume | 1,345,117 | 2,325,509 | 2,450,048 | ||
| Previous | 89.41 | 69.33 | 107.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 87.08 | 64.24 | 93.10 | ||
| 20-Day Raw Stochastic | 62.61% | 73.32% | 93.19% | ||
| 20-Day Relative Strength | 55.08 | 62.43 | 75.54 | ||
| Weighted Alpha | +196.56 | +24.59 | +61.56 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 72% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.20% since 08/13/26 | -1.24% since 08/13/26 | +5.41% since 08/13/26 | ||
| Low | 83.78 on 08/14/26 | 66.21 on 08/17/26 | 98.13 on 08/14/26 | ||
| High | 90.00 on 08/19/26 | 69.62 on 08/19/26 | 107.96 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +22.08% since 07/20/26 | +14.50% since 07/20/26 | +37.66% since 07/20/26 | ||
| Low | 72.62 on 07/21/26 | 57.42 on 07/23/26 | 76.82 on 07/23/26 | ||
| High | 95.49 on 07/22/26 | 70.98 on 08/12/26 | 107.96 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +13.39% since 05/20/26 | +34.82% since 05/20/26 | +53.84% since 05/20/26 | ||
| Low | 69.30 on 06/02/26 | 52.13 on 05/21/26 | 65.60 on 06/02/26 | ||
| High | 95.49 on 07/22/26 | 70.98 on 08/12/26 | 107.96 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +37.55% since 02/20/26 | +5.62% since 02/20/26 | +49.51% since 02/20/26 | ||
| Low | 54.02 on 03/13/26 | 49.26 on 05/18/26 | 61.33 on 03/27/26 | ||
| High | 95.49 on 07/22/26 | 70.98 on 08/12/26 | 107.96 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,594,025 | 13,420,486 | 12,214,655 | ||
| Shares Outstanding, K | 140,857 | 193,574 | 113,498 | ||
| Annual Sales, $M | 829,450,000 | 3,221,250,000 | 1,396,610,000 | ||
| Annual Net Income, $M | -1,630,000 | 348,900,000 | 316,890,000 | ||
| Last Qtr Sales, $M | 75,250,000 | 989,710,000 | 481,000,000 | ||
| Last Qtr Income, $M | -194,280,000 | 44,760,000 | 229,910,000 | ||
| 60-Month Beta | 1.27 | 0.24 | 0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.36 on 08/04/26 | 1.20 on 08/06/26 | 2.28 on 08/06/26 | ||
| Latest Earnings Date | 11/24/26 | 10/26/26 | 11/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 39.88 | 21.28 | ||